secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIM ImmunoTech Inc. (AIM)
CIK:        0000946644
Form:       8-K
Filed at:   2026-09-10T20:35:30+00:00
Accession:  0001493152-26-042196
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AIM ImmunoTech converts $450K of promissory note into 1.92M shares at $0.234/share
--------------------------------------------------------------------------------

- Entered two exchange agreements with Streeterville Capital on Sept 3-4, 2026, converting ~$450,000 of Nov 2025 promissory note.
- Issued 1,921,441 common shares at average conversion price of ~$0.234 per share.
- Stockholders approved conversion at July 15, 2026 special meeting per NYSE American rules.
- Original note principal was $3,301,250; exchange reduces outstanding balance by $450,000.
- Shares issued under Section 3(a)(9) exemption; no commission paid.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946644/000149315226042196/0001493152-26-042196-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946644/000149315226042196/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-042196

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer